Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity

被引:90
作者
Yokozeki, H
Ghoreishi, M
Takagawa, S
Takayama, K
Satoh, T
Katayama, I
Takeda, K
Akira, S
Nishioka, K
机构
[1] Tokyo Med & Dent Univ, Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Nagasaki Univ, Sch Med, Dept Dermatol, Nagasaki 8528102, Japan
[3] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan
关键词
signal transducer and activator of transcription factor 6; contact hypersensitivity; Th2; IL-4; IL-13;
D O I
10.1084/jem.191.6.995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Contact hypersensitivity (CHS) is thought to be mainly associated with the activation of T helper type 1 (Th1) cells. However, there is also evidence that Th2 cells or Th2 cytokines play a role in the development of CHS. To analyze the functional contribution of Th2 cytokines interleukin (IL)-4 and IL-13, signal transducer and activator of transcription 6 (STAT6)-deficient (STAT6(-/-)) and wild-type (wt) control C57BL/6 mice were contact sensitized with 5% 2,4,6-trinitrochlorobenzene (TNCB), 0.5% 2,4-dinitrofluorobenzene, or 5% 4-ethoxyl methylene-2-phenyl-2-oxazolin-5-one, and any skin reactions were examined. Ear swelling was significantly reduced with a delayed peak response in STAT6(-/-) mice compared with wt mice. A histological analysis revealed that the infiltration of both eosinophils and neutrophils in the skin challenged after 24 h in STAT6(-/-) mice decreased substantially compared with that in wt mice. The expression of Th2 cytokines (IL-4, IL-5) in TNCB-challenged skin tissues and the supernatants from T cells stimulated by 2,4,6-trinitrobenzene sulfonate-modified spleen cells, as well as the immunoglobulin (Ig)E and IgG1 response after challenge, were also profoundly reduced in STAT6(-/-) mice, whereas the expression of interferon gamma was the same in STAT6(-/-) and wt mice after challenge. Furthermore, adoptive transfer experiments revealed chat STAT6(-/-) mice induced CHS after injection of lymph node cells obtained from sensitized wt mice. Our data suggest that the STAT6 signal plays a critical role in the induction phase of CHS.
引用
收藏
页码:995 / 1004
页数:10
相关论文
共 35 条
[1]   Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice [J].
Akimoto, T ;
Numata, F ;
Tamura, M ;
Takata, Y ;
Higashida, N ;
Takashi, T ;
Takeda, K ;
Akira, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1537-1542
[2]   Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4 [J].
Asada, H ;
Linton, J ;
Katz, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) :406-411
[3]   Role of IL-4 in delayed type hypersensitivity [J].
Asherson, GL ;
Dieli, F ;
Sireci, G ;
Salerno, A .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) :1-4
[4]   INTERLEUKIN-10 BUT NOT INTERLEUKIN-4 IS A NATURAL SUPPRESSANT OF CUTANEOUS INFLAMMATORY RESPONSES [J].
BERG, DJ ;
LEACH, MW ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
DAVIDSON, NJ ;
RENNICK, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :99-108
[5]   Differentiation of human dendritic cells from monocytes in vitro [J].
Chapuis, F ;
Rosenzwajg, M ;
Yagello, M ;
Ekman, M ;
Biberfeld, P ;
Gluckman, JC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) :431-441
[6]   INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS [J].
DANDREA, A ;
ASTEAMEZAGA, M ;
VALIANTE, NM ;
MA, XJ ;
KUBIN, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1041-1048
[7]  
DIELI F, 1994, J IMMUNOL, V152, P2698
[8]   REGULATION OF CONTACT HYPERSENSITIVITY BY INTERLEUKIN 1O [J].
FERGUSON, TA ;
DUBE, P ;
GRIFFITH, TS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1597-1604
[9]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095
[10]  
GAUTAM SC, 1992, J IMMUNOL, V148, P1411